Evidence map›Paper›PMID 38020797›Full record

ReviewSAGE open medicine2023

Social stigma during COVID-19: A systematic review.

SeyedAhmad SeyedAlinaghi, Amir Masoud Afsahi, Ramin Shahidi, Arian Afzalian, Pegah Mirzapour, Mohammad Eslami, Sepide Ahmadi, Parisa Matini, Soudabeh Yarmohammadi, Seyed Saeed Tamehri Zadeh and 11 more

Abstract readReview
In one paragraph

Review in SAGE open medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

SeyedAhmad SeyedAlinaghiIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Amir Masoud AfsahiDepartment of Radiology, School of Medicine, University of California, San Diego, CA, USA.ORCID https://orcid.org/0000-0002-8906-7767
Ramin ShahidiSchool of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.
Arian AfzalianSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Pegah MirzapourIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad EslamiSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Sepide AhmadiSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Parisa MatiniSchool of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Soudabeh YarmohammadiTrauma Research Center, Kashan University of Medical Sciences, Kashan, Iran.
Seyed Saeed Tamehri ZadehIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Pooria AsiliDepartment of Pathology, Tehran University of Medical Sciences, Tehran, Iran.
Parinaz ParanjkhooTurpanjian College of Health Sciences, American University of Armenia, Yerevan, Armenia.
Maryam RamezaniDepartment of Health Management, Policy and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Sahar Nooralioghli ParikhaniSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Foziye SanaatiSchool of Nursing and Allied Medical Sciences, Maragheh University of Medical Sciences, Maragheh, Iran.
Iman Amiri FardDepartment of Community Health Nursing and Geriatric Nursing, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran.
Elham Emamgholizade BaboliIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Somaye MansouriDepartment of Management, Bandar Abbas Branch, Islamic Azad University, Bandar Abbas, Iran.
Ava PashaeiIranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran.
Esmaeil MehraeenDepartment of Health Information Technology, Khalkhal University of Medical Sciences, Khalkhal, Iran.ORCID https://orcid.org/0000-0003-4108-2973
Daniel HackettFaculty of Medicine and Health, Physical Activity, Lifestyle, Ageing and Wellbeing Faculty Research Group, School of Health Sciences, The University of Sydney, Sydney, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Stigmatization was reported throughout the COVID pandemic for COVID-19 patients and close contacts. The aim of this systematic review was to comprehensively examine the prevalence and impact of stigmatization during COVID-19 pandemic. Methods: English articles were searched using online databases that included PubMed, Scopus, Embase, and Web of Science up to 24 August 2022. A two-step screening and selection process was followed utilizing an inclusion and exclusion criteria and then data was extracted from eligible articles. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist was followed, and the risk of bias was assessed using the Newcastle-Ottawa Scale. Results: Seventy-six studies were eligible for inclusion. Twenty-two studies reported the prevalence of social stigma due to COVID-19 infection with social isolation being the most commonly reported stigma. There were 20 studies that reported the majority of participants experienced stigma due to COVID-19 infection, which was as high as 100% of participants in two studies. Participants in 16 studies reported blaming from others as the second most common type of stigma, with various other types reported such as psychological pressure, verbal violence, avoidance, and labeling. The most common effect of the stigma was anxiety followed by depression, and then reduction of socialization. Conclusion: Findings from the present review have identified that COVID-19-related stigma studies have generally focused on its prevalence, type, and outcome. Greater awareness of this topic may assist with improving public education during pandemics such as COVID-19 as well as access to support services for individuals impacted by stigmatization.

Indexed as

COVID-19public stigmaSARS-CoV-2social stigmastigma

Identifiers

PMID38020797
PMCPMC10640804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.